| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |